Guidance
Annexes to the recommendations for use of the CanSinoBIO Ad5-nCoV-S [recombinant] vaccine (Convidecia™) against COVID-19
Annexes to the recommendations for use of the CanSinoBIO Ad5-nCoV-S [recombinant] vaccine (Convidecia™) against COVID-19: grading of evidence: evidence to recommendation tables, first issuance: 19 May 2022
Authors
Languages
- English
Publication year
2022
Type
Guidance
Categories
- Vaccines & delivery devices
Diseases
- COVID-19
Tags
- New vaccine introduction
